Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Prostate Cancer

‘Nothing to lose and everything to gain’ – Alfred’s story

Read Alfred's story of joining the STAMPEDE clinical trial. His is one of the many stories featured in our 2016/17 Annual Review.

ASCO 2017: 4 ways treatment could change following world’s largest cancer conference

Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.

Blood test could help personalise treatment for advanced prostate cancer

Scientists have developed a blood test that could help doctors select the best treatment for men with aggressive prostate cancer.

‘Once in a career feeling’ as trial shows offering prostate cancer drug earlier improves survival

We take a look at results from the STAMPEDE clinical trial, which is researching how to improve treatment for men with prostate cancer.

Giving prostate cancer drug earlier extends lives of men whose disease has spread

Offering abiraterone (Zytiga) up-front with standard hormone treatment extends survival in men whose prostate cancer has spread.

Adding abiraterone to standard treatment improves prostate cancer survival by 40 per cent

Adding abiraterone to hormone therapy at the start of treatment for prostate cancer improves survival by 37 per cent.

Experimental blood test predicts advanced prostate cancer outcome

A blood test could help predict which advanced prostate cancer patients are likely to do best when treated with certain targeted treatments.

Hormone drug and radiotherapy ‘could extend lives’ of prostate cancer patients after surgery

Men with a high risk of prostate cancer recurrence could live longer if hormone treatment is given alongside radiotherapy after surgery.

MRI scans for suspected prostate cancer could improve diagnosis

Using an MRI scan to help diagnose prostate cancer could spare some men from unnecessary invasive biopsies, according to a new study.

Meet the scientists tackling brain tumours, investigating a cancer ‘master switch’ and much more

Meet our new leaders, who are spearheading research to tackle some of the biggest questions we need to answer to help more people survive cancer.

Pages